Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Ajanta Pharma Ltd.
NSE: AJANTPHARM
|
BSE: 532331
|
ISIN: INE031B01049
|
Industry: Pharmaceuticals
Results
|
Expensive Performer
3381.0000
97.10
(
2.96
%)
NSE
Oct 26, 2026
15:50 PM
41.94% Gain from 52W Low
Volume:
107.1K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Ajanta Pharma Ltd.
29 Jul 2025
Results
3381.00
2.96%
Ajanta Pharma (HOLD): Double-digit growth to continue; EBITDA margin constant
Hold:
Ajanta Pharma Ltd.
by
BOB Capital Markets Ltd.
Target: 2783
Target
BOB Capital Markets Ltd.
Earnings were in line with our estimates with sales /EBITDA/PAT reported 1%/-2.7%/3% above estimates
Ajanta Pharma has gained
22.27%
in the last 6 Months
More from Ajanta Pharma Ltd.
Recommended
Market closes higher, led by IT and financial stocks
Trendlyne Marketwatch |
26 Oct 2026, 04:02PM
Pre Monday: An optimist surveys the market during earnings season
The Baseline |
24 Oct 2026
Ajanta Pharma disputes ET article on FDA import alert
|
24 Jan 2017